• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

草药健康声称的全球协调统一。

Global harmonization of herbal health claims.

作者信息

Mahady G B

机构信息

Program for Collaborative Research in the Pharmaceutical Sciences, College of Pharmacy, University of Illinois at Chicago, Chicago, IL 60612, USA.

出版信息

J Nutr. 2001 Mar;131(3s):1120S-3S. doi: 10.1093/jn/131.3.1120S.

DOI:10.1093/jn/131.3.1120S
PMID:11238830
Abstract

Over the past decade, herbal medicine has become a topic of increasing global importance, with both medical and economic implications. In developing countries, as much as 80% of the indigenous populations depends on traditional systems of medicine and medicinal plants as their primary source of healthcare. Within the European Community, herbal medicines represent an important share of the pharmaceutical market, with annual sales in the range of US$7 billion. In the United States, the sale of herbal products has skyrocketed from $200 million in 1988 to >$3.3 billion in 1997. Such widespread use of botanicals throughout the world has raised serious questions concerning the quality, safety and efficacy of these products. Thus, accurate scientific assessment of herbal medicine is a prerequisite for global harmonization of herbal health claims. In 1995, as part of its overall global strategy of "Health for All" and due to numerous requests from the member states, the Traditional Medicine Program of the WHO began the extensive task of reviewing the world's scientific literature of commonly used herbal medicines and publishing this information in monographs. The WHO monographs are technical reviews of the quality, safety and efficacy of commonly used herbal medicines and are intended primarily to harmonize the proper use of herbal medicines throughout the world.

摘要

在过去十年中,草药已成为一个在全球范围内重要性日益增加的话题,具有医学和经济两方面的影响。在发展中国家,多达80%的本土人口依赖传统医学体系和药用植物作为其主要的医疗保健来源。在欧洲共同体内部,草药在药品市场中占据重要份额,年销售额达70亿美元左右。在美国,草药产品的销售额已从1988年的2亿美元飙升至1997年的超过33亿美元。植物药在全球范围内如此广泛的使用引发了有关这些产品质量、安全性和有效性的严重问题。因此,对草药进行准确的科学评估是全球统一草药健康声称的先决条件。1995年,作为其“人人享有健康”总体全球战略的一部分,并应成员国的众多要求,世界卫生组织传统医学项目开始了一项广泛的任务,即审查世界上关于常用草药的科学文献,并将这些信息发表在专论中。世界卫生组织的专论是对常用草药的质量、安全性和有效性的技术审查,主要目的是在全球范围内统一草药的合理使用。

相似文献

1
Global harmonization of herbal health claims.草药健康声称的全球协调统一。
J Nutr. 2001 Mar;131(3s):1120S-3S. doi: 10.1093/jn/131.3.1120S.
2
The European role on traditional herbal medicinal products and traditional plant food supplements.欧洲传统草药药品和传统植物食品补充剂的作用。
J Clin Gastroenterol. 2012 Oct;46 Suppl:S93-4. doi: 10.1097/MCG.0b013e318266b08f.
3
Regulation of medicinal plants for public health--European community monographs on herbal substances.中药材用于公众健康的监管——欧盟草药专论。
Planta Med. 2012 Aug;78(12):1311-6. doi: 10.1055/s-0031-1298578. Epub 2012 May 22.
4
Non-European traditional herbal medicines in Europe: a community herbal monograph perspective.欧洲的非欧洲传统草药:从社区草药专论角度看
J Ethnopharmacol. 2014 Oct 28;156:107-14. doi: 10.1016/j.jep.2014.08.021. Epub 2014 Aug 27.
5
Future development of global regulations of Chinese herbal products.中草药全球监管法规的未来发展。
J Ethnopharmacol. 2012 Apr 10;140(3):568-86. doi: 10.1016/j.jep.2012.02.029. Epub 2012 Feb 25.
6
Herbal medicines in European regulation.欧洲法规中的草药
Pharmacol Res. 1997 May;35(5):355-62. doi: 10.1006/phrs.1997.0132.
7
Quality assurance and safety of herbal dietary supplements.草药膳食补充剂的质量保证与安全性
J Environ Sci Health C Environ Carcinog Ecotoxicol Rev. 2009 Apr;27(2):91-119. doi: 10.1080/10590500902885676.
8
Future visions for traditional and herbal medicinal products--a global practice for evaluation and regulation?传统和草药产品的未来展望——全球评估与监管实践?
J Ethnopharmacol. 2014 Dec 2;158 Pt B:516-8. doi: 10.1016/j.jep.2014.08.015. Epub 2014 Aug 22.
9
European legislation on herbal medicines: a look into the future.欧洲草药立法:展望未来。
Drug Saf. 2008;31(5):428-31. doi: 10.2165/00002018-200831050-00009.
10
Implementing a "quality by design" approach to assure the safety and integrity of botanical dietary supplements.实施“质量源于设计”方法以确保植物性膳食补充剂的安全性和完整性。
J Nat Prod. 2012 Sep 28;75(9):1665-73. doi: 10.1021/np300434j. Epub 2012 Aug 31.

引用本文的文献

1
Atractylenolide I ameliorated the growth and enzalutamide resistance of castration-resistant prostate cancer by targeting KIF15.白术内酯I通过靶向驱动蛋白家族成员15(KIF15)改善去势抵抗性前列腺癌的生长和恩杂鲁胺耐药性。
Chin Med. 2025 Mar 14;20(1):35. doi: 10.1186/s13020-025-01086-1.
2
Integrating High-Resolution Mass Spectral Data, Bioassays and Computational Models to Annotate Bioactives in Botanical Extracts: Case Study Analysis of Extract Associates Dicaffeoylquinic Acids with Protection against Amyloid-β Toxicity.整合高分辨率质谱数据、生物测定和计算模型以注释植物提取物中的生物活性成分:以 Dicaffeoylquinic Acids 提取物对防治淀粉样β毒性的保护作用为例的分析。
Molecules. 2024 Feb 13;29(4):838. doi: 10.3390/molecules29040838.
3
Protective Effect of Butanolic Fraction of on Fructose-Mediated Metabolic Alterations in Rats.
[某种物质]丁醇部位对大鼠果糖介导的代谢改变的保护作用。 (注:原文中“of”后面缺少具体物质名称)
Metabolites. 2022 May 26;12(6):481. doi: 10.3390/metabo12060481.
4
Identification of Berbamine, Oxyacanthine and Rutin from Berberis asiatica as anti-SARS-CoV-2 compounds: An in silico study.从小檗属植物中鉴定出小檗碱、小檗胺和芦丁作为抗 SARS-CoV-2 化合物:一项计算机研究。
J Mol Graph Model. 2021 Dec;109:108028. doi: 10.1016/j.jmgm.2021.108028. Epub 2021 Oct 11.
5
Antimicrobial Potential of Naturally Occurring Bioactive Secondary Metabolites.天然存在的生物活性次生代谢产物的抗菌潜力
J Pharm Bioallied Sci. 2021 Apr-Jun;13(2):155-162. doi: 10.4103/jpbs.JPBS_753_20. Epub 2021 May 26.
6
Antiurolithic effects of medicinal plants: results of in vivo studies in rat models of calcium oxalate nephrolithiasis-a systematic review.植物类抗结石药物的作用:草酸钙肾结石大鼠模型体内研究结果——系统评价。
Urolithiasis. 2021 Apr;49(2):95-122. doi: 10.1007/s00240-020-01236-0. Epub 2021 Jan 23.
7
Safety Evaluation of α-Lipoic Acid Supplementation: A Systematic Review and Meta-Analysis of Randomized Placebo-Controlled Clinical Studies.补充α-硫辛酸的安全性评估:随机安慰剂对照临床研究的系统评价与荟萃分析
Antioxidants (Basel). 2020 Oct 19;9(10):1011. doi: 10.3390/antiox9101011.
8
The governance of traditional medicine and herbal remedies in the selected local markets of Western Kenya.肯尼亚西部选定地方市场的传统医学和草药疗法治理。
J Ethnobiol Ethnomed. 2020 Jun 26;16(1):39. doi: 10.1186/s13002-020-00389-x.
9
Recognition of Natural Products as Potential Inhibitors of COVID-19 Main Protease (Mpro): In-Silico Evidences.天然产物作为新型冠状病毒主要蛋白酶(Mpro)潜在抑制剂的认识:计算机模拟证据
Nat Prod Bioprospect. 2020 Oct;10(5):297-306. doi: 10.1007/s13659-020-00253-1. Epub 2020 Jun 17.
10
Awareness, Self-Use, Perceptions, Beliefs, and Attitudes toward Complementary and Alternative Medicines (CAM) among Health Professional Students in King Saud bin Abdulaziz University for Health Sciences Jeddah, Saudi Arabia.沙特阿拉伯吉达阿卜杜勒阿齐兹国王健康科学大学健康专业学生对补充和替代医学(CAM)的认知、自我使用情况、看法、信念及态度
Evid Based Complement Alternat Med. 2020 Apr 21;2020:7872819. doi: 10.1155/2020/7872819. eCollection 2020.